Technology
Health
Biotechnology
Immuron
$3.059876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.55 (-15.28%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Immuron and other stocks, options, ETFs, and crypto commission-free!
About IMRN
Immuron Ltd. engages in the research and development of oral immunotherapy treatments using dairy-derived antibody products for humans. It operates through the following segments: Research and Development; HyperImmune Products; and Corporate. Read More The Research and Development segment involves the R&D projects performed in Australia and Israel. The HyperImmune Products segment comprises of Travelan activities which occur in Australia, New Zealand, Canada, and the United States. The Corporate segment covers company activities. The company was founded on January 13, 1994 and is headquartered in Southbank, Australia.
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994
Market Cap
10.92M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.18M
High Today
$3.57
Low Today
$3.11
Open Price
$3.57
Volume
77.03K
52 Week High
$14.29
52 Week Low
$2.38
Collections
Technology
Health
Biotechnology
Research And Development
2013 IPO
IMRN News
Price Paid on Robinhood
65% Lower
Right Now
52 Week Low
$4.85
Average Price Paid
$8.73
52 Week High
$14.29
IMRN Earnings
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
—